Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
385M
-
Number of holders
-
940
-
Total 13F shares, excl. options
-
244M
-
Shares change
-
-2.63M
-
Total reported value, excl. options
-
$34.8B
-
Value change
-
-$410M
-
Put/Call ratio
-
1.17
-
Number of buys
-
416
-
Number of sells
-
-446
-
Price
-
$142.85
Significant Holders of Moderna, Inc. - COMMON STOCK (MRNA) as of Q2 2022
1,154 filings reported holding MRNA - Moderna, Inc. - COMMON STOCK as of Q2 2022.
Moderna, Inc. - COMMON STOCK (MRNA) has 940 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 244M shares
of 385M outstanding shares and own 63.46% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (45.6M shares), VANGUARD GROUP INC (27.6M shares), BlackRock Inc. (26.2M shares), STATE STREET CORP (14.8M shares), Flagship Pioneering Inc. (12.9M shares), Theleme Partners LLP (6.35M shares), GEODE CAPITAL MANAGEMENT, LLC (6.34M shares), COATUE MANAGEMENT LLC (5.71M shares), WELLINGTON MANAGEMENT GROUP LLP (4.37M shares), and MORGAN STANLEY (3.48M shares).
This table shows the top 940 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.